Plexus price target raised to $145 from $120 at Benchmark

Benchmark raised the firm’s price target on Plexus to $145 from $120 and keeps a Buy rating on the shares after the company reported Q3 results and management reaffirmed its 9%-12% year-over-year growth expectation for next year. The firm believes the results and outlook speak to the differentiation of the Plexus model and underlying value creation potential, the analyst tells investors.